| Issue Date | Title | Involved Person(s) |
| 17-Dec-2021 | Effect of the FDA black box suicidality warnings for antidepressants on suicide rates in the USA : signal or noise? | Plöderl, Martin; Hengartner, Michael Pascal |
| Dec-2021 | Evidence-biased antidepressant prescription : overmedicalisation, flawed research, and conflicts of interest | Hengartner, Michael P. |
| 8-Nov-2021 | Learning about the course of suicidal behavior but not about the effects of SSRIs | Plöderl, Martin; Hengartner, Michael Pascal |
| 2021 | Beneficial and harmful effects of antidepressants versus placebo, ‘active placebo’, or no intervention for adults with major depressive disorder : a protocol for a systematic review of published and unpublished data with meta-analyses and trial sequential analyses | Juul, Sophie; Siddiqui, Faiza; Barbateskovic, Marija; Jørgensen, Caroline Kamp; Hengartner, Michael Pascal, et al |
| 2021 | Tricyclic antidepressants versus ‘active placebo’, placebo or no intervention for adults with major depressive disorder : a protocol for a systematic review with meta-analysis and Trial Sequential Analysis | Jørgensen, Caroline Kamp; Juul, Sophie; Siddiqui, Faiza; Barbateskovic, Marija; Munkholm, Klaus, et al |
| 2021 | Swiss GPs’ preferences for antidepressant treatment in mild depression : vignette-based quantitative analysis | Hengartner, Michael P.; Neuner-Jehle, Stefan; Senn, Oliver |
| 25-Nov-2020 | Did the introduction and increased prescribing of antidepressants lead to changes in long-term trends of suicide rates? | Amendola, Simone; Plöderl, Martin; Hengartner, Michael Pascal |
| Aug-2020 | Antidepressiva gegen Depressionen : aktuelle Kontroversen um Nutzen und Risiken | Hengartner, Michael Pascal |
| 2020 | Comparative efficacy of placebos in short-term antidepressant trials for major depression : a secondary meta-analysis of placebo-controlled trials | Holper, Lisa; Hengartner, Michael Pascal |
